Global Blood Therapeutics, Inc. (GBT) Stock Analysis
DELISTED 2022
What happened to Global Blood Therapeutics, Inc. (GBT) stock?
Global Blood Therapeutics, Inc. (GBT) no longer trades on public markets. It was delisted in October 2022. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2022
- Last recorded price (historical):
- $68.49 (last quote on record before the October 2022 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Global Blood Therapeutics, Inc. (GBT). Global Blood Therapeutics (GBT) is a biopharmaceutical company focused on developing and delivering treatments for sickle cell disease (SCD).
Last analyzed: Mar 16, 2026Global Blood Therapeutics, Inc. (GBT) Healthcare & Pipeline Overview
More about this archive record
Can I still buy GBT shares?
No. GBT stopped trading on public markets in October 2022, so the shares are not available through a broker. Anything you see quoted for GBT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GBT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Global Blood Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.